Industry Growth Insights published a new data on “Oncology Drug Market”. The research report is titled “Oncology Drug Market research by Types (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), By Applications (Blood Cancer, Breast Cancer, gastrointestinal Tract Cancer, Prostate Cancer, Lung Cancer, Skin Cancer), By Players/Companies Roche Ltd, Novartis AG, Bristol-Myers Squibb, Celgene Corporation, Johnson & Johnson, Pfizer Inc., Astra Zenca Plc, Eli Lilly And Company., Glaxosmithkline Plc, Merck & Co., Sanofi, Amgen Inc., Abbvie”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oncology Drug Market Research Report
By Type
Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others
By Application
Blood Cancer, Breast Cancer, gastrointestinal Tract Cancer, Prostate Cancer, Lung Cancer, Skin Cancer
By Companies
Roche Ltd, Novartis AG, Bristol-Myers Squibb, Celgene Corporation, Johnson & Johnson, Pfizer Inc., Astra Zenca Plc, Eli Lilly And Company., Glaxosmithkline Plc, Merck & Co., Sanofi, Amgen Inc., Abbvie
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Oncology Drug Market Report Segments:
The global Oncology Drug market is segmented on the basis of:
Types
Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Blood Cancer, Breast Cancer, gastrointestinal Tract Cancer, Prostate Cancer, Lung Cancer, Skin Cancer
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Ltd
- Novartis AG
- Bristol-Myers Squibb
- Celgene Corporation
- Johnson & Johnson
- Pfizer Inc.
- Astra Zenca Plc
- Eli Lilly And Company.
- Glaxosmithkline Plc
- Merck & Co.
- Sanofi
- Amgen Inc.
- Abbvie
Highlights of The Oncology Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Hormonal Therapy
- Others
- By Application:
- Blood Cancer
- Breast Cancer
- gastrointestinal Tract Cancer
- Prostate Cancer
- Lung Cancer
- Skin Cancer
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oncology Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oncology drugs are medications used to treat cancer. They can be grouped into two main types: targeted therapies and chemotherapy. Targeted therapies are drugs that specifically target the cancer cells, while chemotherapy is a combination of different drugs that work together to kill the cancer cells.
Some of the major players in the oncology drug market are Roche Ltd, Novartis AG, Bristol-Myers Squibb, Celgene Corporation, Johnson & Johnson, Pfizer Inc., Astra Zenca Plc, Eli Lilly And Company., Glaxosmithkline Plc, Merck & Co., Sanofi, Amgen Inc., Abbvie.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oncology Drug Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oncology Drug Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oncology Drug Market - Supply Chain
4.5. Global Oncology Drug Market Forecast
4.5.1. Oncology Drug Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oncology Drug Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oncology Drug Market Absolute $ Opportunity
5. Global Oncology Drug Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oncology Drug Market Size and Volume Forecast by Type
5.3.1. Chemotherapy
5.3.2. Targeted Therapy
5.3.3. Immunotherapy
5.3.4. Hormonal Therapy
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oncology Drug Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oncology Drug Market Size and Volume Forecast by Application
6.3.1. Blood Cancer
6.3.2. Breast Cancer
6.3.3. gastrointestinal Tract Cancer
6.3.4. Prostate Cancer
6.3.5. Lung Cancer
6.3.6. Skin Cancer
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oncology Drug Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oncology Drug Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oncology Drug Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oncology Drug Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oncology Drug Demand Share Forecast, 2019-2029
9. North America Oncology Drug Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oncology Drug Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oncology Drug Market Size and Volume Forecast by Application
9.4.1. Blood Cancer
9.4.2. Breast Cancer
9.4.3. gastrointestinal Tract Cancer
9.4.4. Prostate Cancer
9.4.5. Lung Cancer
9.4.6. Skin Cancer
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oncology Drug Market Size and Volume Forecast by Type
9.7.1. Chemotherapy
9.7.2. Targeted Therapy
9.7.3. Immunotherapy
9.7.4. Hormonal Therapy
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oncology Drug Demand Share Forecast, 2019-2029
10. Latin America Oncology Drug Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oncology Drug Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oncology Drug Market Size and Volume Forecast by Application
10.4.1. Blood Cancer
10.4.2. Breast Cancer
10.4.3. gastrointestinal Tract Cancer
10.4.4. Prostate Cancer
10.4.5. Lung Cancer
10.4.6. Skin Cancer
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oncology Drug Market Size and Volume Forecast by Type
10.7.1. Chemotherapy
10.7.2. Targeted Therapy
10.7.3. Immunotherapy
10.7.4. Hormonal Therapy
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oncology Drug Demand Share Forecast, 2019-2029
11. Europe Oncology Drug Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oncology Drug Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oncology Drug Market Size and Volume Forecast by Application
11.4.1. Blood Cancer
11.4.2. Breast Cancer
11.4.3. gastrointestinal Tract Cancer
11.4.4. Prostate Cancer
11.4.5. Lung Cancer
11.4.6. Skin Cancer
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oncology Drug Market Size and Volume Forecast by Type
11.7.1. Chemotherapy
11.7.2. Targeted Therapy
11.7.3. Immunotherapy
11.7.4. Hormonal Therapy
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oncology Drug Demand Share, 2019-2029
12. Asia Pacific Oncology Drug Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oncology Drug Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oncology Drug Market Size and Volume Forecast by Application
12.4.1. Blood Cancer
12.4.2. Breast Cancer
12.4.3. gastrointestinal Tract Cancer
12.4.4. Prostate Cancer
12.4.5. Lung Cancer
12.4.6. Skin Cancer
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oncology Drug Market Size and Volume Forecast by Type
12.7.1. Chemotherapy
12.7.2. Targeted Therapy
12.7.3. Immunotherapy
12.7.4. Hormonal Therapy
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oncology Drug Demand Share, 2019-2029
13. Middle East & Africa Oncology Drug Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oncology Drug Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oncology Drug Market Size and Volume Forecast by Application
13.4.1. Blood Cancer
13.4.2. Breast Cancer
13.4.3. gastrointestinal Tract Cancer
13.4.4. Prostate Cancer
13.4.5. Lung Cancer
13.4.6. Skin Cancer
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oncology Drug Market Size and Volume Forecast by Type
13.7.1. Chemotherapy
13.7.2. Targeted Therapy
13.7.3. Immunotherapy
13.7.4. Hormonal Therapy
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oncology Drug Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Oncology Drug Market: Market Share Analysis
14.2. Oncology Drug Distributors and Customers
14.3. Oncology Drug Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche Ltd
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Novartis AG
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bristol-Myers Squibb
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Celgene Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Johnson & Johnson
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pfizer Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Astra Zenca Plc
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Eli Lilly And Company.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Glaxosmithkline Plc
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Merck & Co.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Sanofi
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Amgen Inc.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Abbvie
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook